Moleculin Biotech, Inc.

NasdaqCM:MBRX Stock Report

Market Cap: US$5.5m

Moleculin Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MBRX?
Owner TypeNumber of SharesOwnership Percentage
Private Companies7,0000.233%
Individual Insiders93,2783.11%
Institutions170,6065.68%
Hedge Funds300,98810%
General Public2,430,02380.9%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 34.8%.

Top Shareholders

Top 24 shareholders own 19.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10%
Armistice Capital LLC
300,988US$547.8k92.9%0.01%
2.43%
Walter Klemp
72,935US$132.7k29.6%no data
2.38%
The Vanguard Group, Inc.
71,403US$130.0k-15.4%no data
1.2%
LPL Financial Corporation, Asset Management Arm
36,103US$65.7k6.96%no data
0.73%
Geode Capital Management, LLC
21,818US$39.7k10.4%no data
0.42%
BlackRock, Inc.
12,475US$22.7k0%no data
0.38%
Jonathan Foster
11,363US$20.7k0%no data
0.37%
Renaissance Technologies LLC
10,996US$20.0k0%no data
0.35%
BB&T Trust
10,500US$19.1k0%no data
0.27%
Donald Picker
8,001US$14.6k0%no data
0.23%
Breitling Energy Corporation
7,000US$12.7k0%no data
0.11%
Atticus Wealth Management, LLC
3,334US$6.1k0%no data
0.06%
Tower Research Capital Europe Limited
1,811US$3.3k-9.22%no data
0.046%
Newbridge Financial Services Group, Inc.
1,367US$2.5k0%no data
0.033%
Robert George
979US$1.8k0.1%no data
0.015%
Morgan Stanley, Investment Banking and Brokerage Investments
449US$817.35.4%no data
0.0048%
Bank of America Corporation, Asset Management Arm
143US$260.1472%no data
0.003%
Sandy Spring Bank, Asset Management Arm
89US$161.70%no data
0.0014%
Securities America Advisors, Inc.
42US$76.50%no data
0.0011%
Class VI Family Office, LLC
34US$61.70%no data
0.00077%
Advisor Group Holdings, Inc., Asset Management Arm
23US$42.10%no data
0.00057%
North Star Investment Management Corporation
17US$31.10%no data
0.00003%
RBC Dominion Securities Inc., Asset Management Arm
1US$1.60%no data
0.00003%
JPMorgan Chase & Co, Brokerage and Securities Investments
1US$1.6-83.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 03:13
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Moleculin Biotech, Inc. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason McCarthyMaxim Group
Kevin DeGeeterOppenheimer & Co. Inc.
null nullRoth MKM